Neurocrine Biosciences, Inc. (NBIX) Posts Q1 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $140.09 +4.81%
Revenue Growth %: +25.6%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
SEIC, OSBC, USAP, More
Revenue Growth %: +25.6%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
SEIC, OSBC, USAP, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- Enphase Energy tumbles on guidance miss; BMO trims estimates and price target
- West Fraser Timber Co. Ltd. (WFG) Tops Q1 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
